Gemigliptin is under investigation in Type 2 Diabetes Mellitus. Gemigliptin has been investigated for the treatment of Cancer and Cisplatin Adverse Reaction.
Seoul National University Bundang Hospital, Seongnam, Gyeonggi, Korea, Republic of
Yonsei University Wonju College of Medicine, Wonju, Gangwondo, Korea, Republic of
Faculty of Medicine ,Vajira Hospital, Bangkok, Thailand
Department of Medicine,Police General Hospital,Thailand, Bangkok, Thailand
2 Division of Nephrology,Department of Medicine Pramongkutklao Hospital and College of Medicine,Thailand, Bangkok, Thailand
LG chem, Seoul, Gangseo-Gu, Korea, Republic of
Unidad de Farmacología Clínica de la Facultad de Medicina de la Universidad Nacional Autónoma de México, Nezahualcóyotl, Estado de México, Mexico
Boramae medical center, Seoul, Korea, Republic of
Pusan National University Hospital, Busan, Korea, Republic of
Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of
Seoul National University Hospital, Seoul, Korea, Republic of
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.